Gunnar Kvalheim

7.5k total citations
173 papers, 5.5k citations indexed

About

Gunnar Kvalheim is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Gunnar Kvalheim has authored 173 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 82 papers in Immunology and 58 papers in Molecular Biology. Recurrent topics in Gunnar Kvalheim's work include Immunotherapy and Immune Responses (60 papers), CAR-T cell therapy research (36 papers) and RNA Interference and Gene Delivery (26 papers). Gunnar Kvalheim is often cited by papers focused on Immunotherapy and Immune Responses (60 papers), CAR-T cell therapy research (36 papers) and RNA Interference and Gene Delivery (26 papers). Gunnar Kvalheim collaborates with scholars based in Norway, Germany and Sweden. Gunnar Kvalheim's co-authors include Gustav Gaudernack, Bjørn Naume, Elin Borgen, Steinar Aamdal, Stein Kvaløy, Rolf Kåresen, Øystein Fodstad, Jahn M. Nesland, Stein Sæbøe‐Larssen and Jahn M. Nesland and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Gunnar Kvalheim

172 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Kvalheim Norway 43 2.9k 1.8k 1.7k 890 826 173 5.5k
Mary M. Zutter United States 43 1.5k 0.5× 1.4k 0.7× 2.6k 1.6× 1.0k 1.2× 571 0.7× 90 6.8k
Frederic I. Preffer United States 43 2.0k 0.7× 2.3k 1.2× 2.0k 1.2× 620 0.7× 905 1.1× 112 7.0k
Kiyohiko Hatake Japan 41 2.3k 0.8× 1.2k 0.7× 1.3k 0.8× 527 0.6× 1.1k 1.3× 237 5.1k
Joost J. van den Oord Belgium 48 1.9k 0.7× 1.8k 1.0× 2.8k 1.6× 1.3k 1.5× 532 0.6× 167 7.8k
Gerhard Moldenhauer Germany 52 2.7k 0.9× 2.9k 1.6× 3.4k 2.0× 860 1.0× 548 0.7× 129 7.6k
Parkash S. Gill United States 52 3.2k 1.1× 1.2k 0.7× 3.2k 1.9× 744 0.8× 1.4k 1.7× 165 8.2k
Yoshito Ueyama Japan 41 2.6k 0.9× 1.3k 0.7× 3.2k 1.9× 1.0k 1.1× 349 0.4× 198 6.5k
Stefano Indraccolo Italy 47 2.5k 0.9× 1.4k 0.7× 3.5k 2.1× 2.2k 2.4× 595 0.7× 209 7.0k
Karl Sotlar Germany 49 1.4k 0.5× 4.1k 2.2× 1.7k 1.0× 740 0.8× 657 0.8× 207 8.4k
Brenda J. Weigel United States 44 2.3k 0.8× 1.4k 0.8× 1.9k 1.2× 688 0.8× 942 1.1× 164 5.8k

Countries citing papers authored by Gunnar Kvalheim

Since Specialization
Citations

This map shows the geographic impact of Gunnar Kvalheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Kvalheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Kvalheim more than expected).

Fields of papers citing papers by Gunnar Kvalheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Kvalheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Kvalheim. The network helps show where Gunnar Kvalheim may publish in the future.

Co-authorship network of co-authors of Gunnar Kvalheim

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Kvalheim. A scholar is included among the top collaborators of Gunnar Kvalheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Kvalheim. Gunnar Kvalheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mensali, Nadia, Amalie Grenov, Niladri Bhusan Pati, et al.. (2019). Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity. OncoImmunology. 8(3). 1558663–1558663. 22 indexed citations
2.
Köksal, Hakan, Pierre Dillard, Sólrún Melkorka Maggadóttir, et al.. (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances. 3(8). 1230–1243. 39 indexed citations
3.
Brinch, Lorentz, Geir E. Tjønnfjord, Tobias Gedde‐Dahl, et al.. (2014). Allogen stamcelletransplantasjon hos voksne 1985 – 2012. Tidsskrift for Den norske legeforening. 134(16). 1569–1575. 3 indexed citations
4.
Wu, Xueping, Xiaoran Li, Gunnar Kvalheim, et al.. (2013). Blocking mtDNA Replication Upregulates the Expression of Stemness-related Genes in Prostate Cancer Cell Lines. Ultrastructural Pathology. 37(4). 258–266. 3 indexed citations
5.
Wang, Ping, Zhenhe Suo, Mengyu Wang, et al.. (2013). In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Experimental Hematology and Oncology. 2(1). 16–16. 8 indexed citations
6.
Vik-Mo, Einar Osland, Marta Nyakas, Morten Carstens Moe, et al.. (2013). Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunology Immunotherapy. 62(9). 1499–1509. 257 indexed citations
7.
Tamburstuen, Margareth V., Sjur Reppe, Axel Spahr, et al.. (2010). Ameloblastin promotes bone growth by enhancing proliferation of progenitor cells and by stimulating immunoregulators. European Journal Of Oral Sciences. 118(5). 451–459. 26 indexed citations
8.
Naume, Bjørn, Xi Zhao, Marit Synnestvedt, et al.. (2007). Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology. 1(2). 160–171. 113 indexed citations
9.
Sæbøe‐Larssen, Stein, et al.. (2007). A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines. BMC Cancer. 7(1). 119–119. 47 indexed citations
10.
11.
Smeland, Sigbjørn, Anne Kirsti Blystad, Stein Kvaløy, et al.. (2004). Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Annals of Oncology. 15(7). 1072–1078. 51 indexed citations
12.
Kvalheim, Gunnar, Aloïs Gratwohl, & Álvaro Urbano-Ispizúa. (2003). JACIE accreditation in Europe moves ahead. Cytotherapy. 5(4). 306–308. 7 indexed citations
13.
Mu, Lijun, et al.. (2003). A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer Vaccines. Scandinavian Journal of Immunology. 58(5). 578–586. 49 indexed citations
14.
Holte, Harald, et al.. (2001). Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.. PubMed. 64. 14–20. 6 indexed citations
15.
Kvalheim, Gunnar, Álvaro Urbano-Ispizúa, & Aloïs Gratwohl. (2000). FAHCT-JACIE workshop on accreditation for blood and marrow progenitor cell processing, collection and transplantation Barcelona, Spain January 22-23, 2000. Cytotherapy. 2(3). 223–224. 2 indexed citations
16.
Larsen, Roy H., et al.. (2000). Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate 211At-rituximab against non-Hodgkin's lymphoma cells. British Journal of Cancer. 83(10). 1375–1379. 32 indexed citations
17.
Davidson, Ben, Bjørn Risberg, Gunnar B. Kristensen, et al.. (1999). Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(1). 43–49. 91 indexed citations
18.
Naume, Bjørn, Elin Borgen, Klaus Beiske, et al.. (1997). Immunomagnetic Techniques for the Enrichment and Detection of Isolated Breast Carcinoma Cells in Bone Marrow and Peripheral Blood. Journal of Hematotherapy. 6(2). 103–114. 98 indexed citations
19.
Kvalheim, Gunnar, et al.. (1996). Immunomagnetic Purging of Lymphoma Cells from Autografts. Journal of Hematotherapy. 5(5). 561–562. 3 indexed citations
20.
Kvalheim, Gunnar, Anne Pharo, Harald Holte, et al.. (1996). Purging of Tumor Cells from Leukapheresis Products: Experimental and Clinical Aspects. Journal of Hematotherapy. 5(4). 427–436. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary M. Zutter Breakdown of academic impact, for papers by Frederic I. Preffer Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Joost J. van den Oord Breakdown of academic impact, for papers by Gerhard Moldenhauer Breakdown of academic impact, for papers by Parkash S. Gill Breakdown of academic impact, for papers by Yoshito Ueyama Breakdown of academic impact, for papers by Stefano Indraccolo Breakdown of academic impact, for papers by Karl Sotlar Breakdown of academic impact, for papers by Brenda J. Weigel
Rankless by CCL
2026